These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29577420)

  • 1. Infarction of the septomarginal band and tricuspid papillary muscle rupture related to alcohol septal ablation for hypertrophic cardiomyopathy.
    Sari M; Izgi C; Kahveci G; Kilicgedik A; Bayram Z; Hatipoglu S; Pala S; Ozdemir N
    Echocardiography; 2018 Jun; 35(6):880-884. PubMed ID: 29577420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
    Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOLFOX chemotherapy as a cause of ventricular septal rupture after alcohol septal ablation for obstructive hypertrophic cardiomyopathy?
    Liebregts M; Bol GM; Groen JW; Lieuw-a-Fa M; Heijmen RH; ten Berg JM
    Int J Cardiol; 2016 Mar; 207():208-10. PubMed ID: 26803246
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging.
    van Dockum WG; ten Cate FJ; ten Berg JM; Beek AM; Twisk JW; Vos J; Hofman MB; Visser CA; van Rossum AC
    J Am Coll Cardiol; 2004 Jan; 43(1):27-34. PubMed ID: 14715178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disappearance of septal Q waves following percutaneous transluminal septal myocardial ablation for obstructive hypertrophic cardiomyopathy.
    Cheng TO
    Am J Cardiol; 2003 Feb; 91(4):515-6. PubMed ID: 12586287
    [No Abstract]   [Full Text] [Related]  

  • 7. Papillary muscle insertion directly into the anterior mitral leaflet in hypertrophic cardiomyopathy, its identification and cause of outflow obstruction by cardiac magnetic resonance imaging, and its surgical management.
    Rowin EJ; Maron BJ; Lesser JR; Rastegar H; Maron MS
    Am J Cardiol; 2013 Jun; 111(11):1677-9. PubMed ID: 23499271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear magnetic resonance for the assessment of the effects of alcohol septal ablation in hypertrophic cardiomyopathy.
    Kornacewicz-Jach Z; Wojtarowicz A; Goos H; Schulz-Menger J; Goracy J; Płońska E; Przybycień K
    Kardiol Pol; 2004 Nov; 61(11):461-7. PubMed ID: 15883594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and mechanism of persistent systolic anterior motion and mitral regurgitation after septal ablation in obstructive hypertrophic cardiomyopathy.
    Delling FN; Sanborn DY; Levine RA; Picard MH; Fifer MA; Palacios IF; Lowry PA; Vlahakes GJ; Vaturi M; Hung J
    Am J Cardiol; 2007 Dec; 100(11):1691-5. PubMed ID: 18036370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Septal myectomy, papillary muscle resection, and mitral valve replacement for hypertrophic obstructive cardiomyopathy: a case report.
    Takahashi J; Wakamatsu Y; Okude J; Gohda T; Sanefuji Y; Kanaoka T; Sasaki S; Matsui Y
    Ann Thorac Cardiovasc Surg; 2008 Aug; 14(4):258-62. PubMed ID: 18818579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute myocardial infarction with left ventricular free wall rupture and papillary muscle rupture caused by infectious endocarditis].
    Amano H; Kanazawa H; Nakazawa S; Shiraishi S; Aoki K; Takahashi Y
    Kyobu Geka; 2006 Mar; 59(3):193-6. PubMed ID: 16528990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: An Echocardiography and Cardiovascular Magnetic Resonance Imaging Study.
    Lu M; Du H; Gao Z; Song L; Cheng H; Zhang Y; Yin G; Chen X; Ling J; Jiang Y; Wang H; Li J; Huang J; He Z; Zhao S
    Circ Cardiovasc Interv; 2016 Mar; 9(3):e002675. PubMed ID: 26884612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of myocardial contrast echocardiographic quantification of risk area for predicting postprocedural complications in patients undergoing septal ethanol ablation for obstructive hypertrophic cardiomyopathy.
    Monakier D; Woo A; Puri T; Schwartz L; Ross J; Jamorski M; Yang H; Liu Z; Vannan M; Wigle ED; Rakowski H
    Am J Cardiol; 2004 Dec; 94(12):1515-22. PubMed ID: 15589007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Moving left ventricular obstruction" due to stress cardiomyopathy in a patient with hypertrophic obstructive cardiomyopathy treated with percutaneous transluminal septal myocardial ablation.
    Akita K; Maekawa Y; Tsuruta H; Okuda S; Yanagisawa R; Kageyama T; Kawakami T; Kanazawa H; Hayashida K; Yuasa S; Murata M; Jinzaki M; Fukuda K
    Int J Cardiol; 2016 Jan; 202():194-5. PubMed ID: 26397409
    [No Abstract]   [Full Text] [Related]  

  • 15. Complications of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Zhang W; Li Z; Zhang M; Yuan L; Guan R; Hou A; Jin Y; Deng Z
    Chin Med J (Engl); 2002 Sep; 115(9):1283-6. PubMed ID: 12411095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Septal myectomy for hypertrophic obstructive cardiomyopathy: coil, boil and the role of rescue surgery.
    Carrel T; Schmidli J
    Eur J Cardiothorac Surg; 2009 Jul; 36(1):210-1. PubMed ID: 19410479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular arrhythmias originating from papillary muscles in the right ventricle.
    Crawford T; Mueller G; Good E; Jongnarangsin K; Chugh A; Pelosi F; Ebinger M; Oral H; Morady F; Bogun F
    Heart Rhythm; 2010 Jun; 7(6):725-30. PubMed ID: 20206325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy, it is not the speed of intracoronary alcohol injection but the amount of alcohol injected that determines the resultant infarct size.
    Cheng TO
    Circulation; 2004 Jul; 110(3):e23; author reply e23. PubMed ID: 15262858
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence for Left Ventricular Outflow Tract Obstruction With Minimal Septal Hypertrophy: The Case Grows Stronger for a Multimodality Imaging Strategy for Hypertrophic Cardiomyopathy.
    Rowin EJ; Maron MS
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003588. PubMed ID: 26082556
    [No Abstract]   [Full Text] [Related]  

  • 20. Extent of myocardial infarction and reverse remodeling assessed by cardiac magnetic resonance in patients with and without right bundle branch block following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    McCann GP; Van Dockum WG; Beek AM; Nijveldt R; Ten Cate FJ; Ten Berg JM; Van Rossum AC
    Am J Cardiol; 2007 Feb; 99(4):563-7. PubMed ID: 17293204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.